IAN LEITH reports on a trip to Argentina where a Caithness group met descendants of the families who made new lives for themselves in Patagonia.
A team of researchers from across Scotland and England has demonstrated how biological systems could transform the way ...
Bio-Rad remains undervalued, but persistent end-market headwinds and limited core growth drivers temper my conviction. BIO's valuation is heavily influenced by its substantial Sartorius stake, and the ...
Distribution has secured funding of £380,000 for three innovation projects, including a collaboration with Scottish ...
Passage Bio, Inc., a genetic medicines company, develops gene therapies for central nervous system diseases. It develops PBGM01, a functional GLB1 gene encoding ß-galactosidase for infantile GM1; ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results